Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1562
| Despition | TAGLN3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1253 | Pin1 Blocking Peptide (AC1253) | 250 µg | inquiry |
| ACPP-1711 | Human PEBP1 Protein (AC1711) | 10 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
| ACPP-1169 | proBNP Blocking Peptide (AC1169) | 250 µg | inquiry |
| ACPP-1013 | Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) | 50 µg | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
| ACPP-1568 | Human NME4 Protein (AC1568) | 5 µg | inquiry |
| ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
| ACPP-1179 | Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) (AC1179) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.